One of the most potent approaches in the management of T2DM is by Dipeptidyl peptidase (IV) inhibition, where the inhibitor of these enzymes will prevent the degradation of the incretin hormone, which in turn increase the insulin secretion and lowering blood glucose level.6 Here, INS is linked to type 2 diabetes mellitus.